The 45-year-old Sami Chugg, 45, was diagnosed with MS 12 years ago and says she was numb and unable to move until she tried an alternative treatment known as Bee Venom Therapy or Apitherapy.
The treatment involves holding a live bee in a pair of tweezers and deliberately stinging an area around the spine.
Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses
Miss Chugg says she was stung around 1,500 times in a year and a half and feels much healthier.
She said: “Most people would be terrified by the prospect of being stung by a bee. But when you have a condition like MS, that involves the numbing of the total body, any kind of sensation is welcome - even if it's from a bee sting. Then you gradually de-sensitize your body to the sting by injecting it in and out of your skin a few times, very cautiously, in case your body is prone to anaphylactic shock – which can be fatal.”
Study Reveals A Simple Blood Test That May Help Predict Severity Of Multiple Sclerosis
University College London scientists have revealed that a simple blood test may soon help predict the severity of multiple sclerosis (MS).
University College London scientists have revealed that a simple blood test may soon help predict the severity of multiple sclerosis (MS).
Researchers claim that certain compounds in bee venom reduce inflammation and pain and a combination of all its ingredients helps the body to release natural healing compounds and has been used to treat other wasting diseases and arthritis.
Advertisement
Promising New Therapy for Relapsing Multiple Sclerosis
A new study has revealed that patients with relapsing multiple sclerosis who combine standard treatment with doses of a humanized monoclonal antibody called daclizumab might fewer relapses
A new study has revealed that patients with relapsing multiple sclerosis who combine standard treatment with doses of a humanized monoclonal antibody called daclizumab might fewer relapses
TRI
Understanding the Onset Mechanism for Multiple Sclerosis
Researchers from the Catholic University of Rome have identified a possible onset mechanism for multiple sclerosis.
Researchers from the Catholic University of Rome have identified a possible onset mechanism for multiple sclerosis.
